YEVGENIY KHARITON to Angiotensin-Converting Enzyme Inhibitors
This is a "connection" page, showing publications YEVGENIY KHARITON has written about Angiotensin-Converting Enzyme Inhibitors.
Connection Strength
0.220
-
Target Doses of Heart Failure Medical?Therapy and Blood Pressure: Insights From the CHAMP-HF Registry. JACC Heart Fail. 2019 04; 7(4):350-358.
Score: 0.142
-
Association between sacubitril/valsartan initiation and real-world health status trajectories over 18?months in heart failure with reduced ejection fraction. ESC Heart Fail. 2021 08; 8(4):2670-2678.
Score: 0.042
-
Association of Changes in Heart?Failure Treatment With Patients' Health Status: Real-World Evidence From CHAMP-HF. JACC Heart Fail. 2019 07; 7(7):615-625.
Score: 0.036